Trial
NCT00447122
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Brown University
Collaborators
Rhode Island Hospital; The Miriam Hospital; Memorial Hospital of Rhode Island
Condition
Metastatic Pancreatic Cancer
Intervention
Gemcitabine 1000mg/m2 30 minutes
Why stopped
slow enrollment and lack of funding
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-03-08